| Abeera A Khan, MD | |
|
2500 English Creek Ave Bldg 800, Egg Harbor Township, NJ 08234-5549 | |
| (609) 407-2277 | |
| Not Available |
| Full Name | Abeera A Khan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 2500 English Creek Ave Bldg 800, Egg Harbor Township, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518377258 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA10534800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlanticare Regional Medical Center | Atlantic city, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlanticare Physician Group Pa | 8527953660 | 495 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
Ongoing European Research Council-funded research at Waterford Institute of Technology's Macular Pigment Research Group is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
Sermo, the world's largest online community for physicians, today announced the results of its most popular discussion poll in the web site's 5-year history. Physicians from all 50 states and representing more than 50 medical specialties offered their insights and opinions to this fundamental question.
› Verified 9 days ago
| Entity Name | Atlanticare Physician Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093829608 PECOS PAC ID: 8527953660 Enrollment ID: O20040218000405 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
Ongoing European Research Council-funded research at Waterford Institute of Technology's Macular Pigment Research Group is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
Sermo, the world's largest online community for physicians, today announced the results of its most popular discussion poll in the web site's 5-year history. Physicians from all 50 states and representing more than 50 medical specialties offered their insights and opinions to this fundamental question.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abeera A Khan, MD 6550 Delilah Rd Ste 309b, Egg Harbor Township, NJ 08234-5102 Ph: (609) 272-2500 | Abeera A Khan, MD 2500 English Creek Ave Bldg 800, Egg Harbor Township, NJ 08234-5549 Ph: (609) 407-2277 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
Ongoing European Research Council-funded research at Waterford Institute of Technology's Macular Pigment Research Group is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
Sermo, the world's largest online community for physicians, today announced the results of its most popular discussion poll in the web site's 5-year history. Physicians from all 50 states and representing more than 50 medical specialties offered their insights and opinions to this fundamental question.
› Verified 9 days ago
Dr. Timothy M. Slaven, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave., Bldg 200, Suite 211, Egg Harbor Township, NJ 08234 Phone: 609-677-7776 Fax: 609-677-7509 | |
Catherine Dillane, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 211, Egg Harbor Township, NJ 08234 Phone: 609-677-7776 Fax: 609-677-7509 | |
Nikhilesh D Mehta, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3205 Fire Road, Suite 4, Egg Harbor Township, NJ 08234 Phone: 609-407-1220 Fax: 609-407-7149 | |
Dr. Thomas Clyde, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2500 English Creek Ave Ste 904, Egg Harbor Township, NJ 08234 Phone: 609-407-2243 | |
Dr. Sridevi Yangala, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave., Bldg 1000, Ste 1002, Egg Harbor Township, NJ 08234 Phone: 609-407-2310 Fax: 609-407-2311 | |
Loreta Garretson, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave, Bldg 400, 2nd Fl, Egg Harbor Township, NJ 08234 Phone: 609-677-7777 Fax: 609-677-6727 | |
Dr. Shikha Broker, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 1002, Egg Harbor Township, NJ 08234 Phone: 609-407-2310 Fax: 609-407-2311 |